Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Merck
McKinsey
Express Scripts
Boehringer Ingelheim

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

Crisaborole - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for crisaborole and what is the scope of freedom to operate?

Crisaborole is the generic ingredient in one branded drug marketed by Anacor Pharms Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Crisaborole has one hundred and twenty-three patent family members in twenty-four countries.

There are three drug master file entries for crisaborole. One supplier is listed for this compound.

Summary for crisaborole
International Patents:123
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 3
Suppliers / Packagers: 1
Bulk Api Vendors: 67
Clinical Trials: 13
Patent Applications: 40
DailyMed Link:crisaborole at DailyMed
Recent Clinical Trials for crisaborole

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 3
Ann & Robert H Lurie Children's Hospital of ChicagoPhase 4
Innovaderm Research Inc.Phase 4

See all crisaborole clinical trials

Pharmacology for crisaborole
Synonyms for crisaborole
1073669-75-6
1187189-21-4
4-((1-HYDROXY-1,3-DIHYDROBENZO-[C][1,2]OXABOROL-5-YL)OXY)BENZONITRILE
4-((1-Hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-6-yl)oxy)benzonitrile
4-((1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile
4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzonitrile
4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile
4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile
4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile
5-(4-cyanophenoxy)-1-hydroxy-2,1-benzoxaborole
5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole
5098AC
906673-24-3
ABP001114
AC-30331
AK102641
AKOS016005425
AN 2728
AN-2728
AN2728
ANW-65536
API0013781
AX8234180
BC245091
BCP08677
BDBM50277665
Benzonitrile, 4-((1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy)-
Benzonitrile, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-
C14H10BNO3
CHEBI:134677
CHEMBL484785
compound 5b [PMID: 19303290]
Crisaborole (USAN/INN)
Crisaborole [USAN:INN]
Crisaborole topical ointment 2%
Crisaborole, >=98% (HPLC)
Crisaborole(AN-2728)
CS-1057
CTK8C0958
D10873
DB-078771
DB05219
DTXSID10238231
Eucrisa
Eucrisa (TN)
EX-A1087
FT-0767999
GTPL9151
HY-10978
KB-40872
KS-0000063U
MolPort-023-332-548
NCGC00345792-01
NCGC00345792-02
Q2R47HGR7P
SB16802
SCHEMBL595261
ST24042710
TC-154281
UNII-Q2R47HGR7P
USZAGAREISWJDP-UHFFFAOYSA-N
W-5676
ZINC169748244

US Patents and Regulatory Information for crisaborole

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes   See Pricing   See Pricing   See Pricing
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes   See Pricing   See Pricing   See Pricing
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes   See Pricing   See Pricing Y Y   See Pricing
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes   See Pricing   See Pricing   See Pricing
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes   See Pricing   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Harvard Business School
Merck
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.